MedTrace Logo

Epidemiology of Bacteremia at Two Tertiary ICUs in Switzerland

NCT05236283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 395

Last updated 2023-01-26

No results posted yet for this study

Summary

The objectives of the retrospective cohort study is to describe the actual current practice of antibiotic treatment duration for bloodstream infections in critically ill patients at two tertiary hospitals (ICU Inselspital Bern and ICU CHUV Lausanne), to examine patient, pathogen and infectious syndrome factors associated with selection of shortened treatment duration, and to describe the expected time course of clinical resolution among bacteremic patients.

Conditions

  • Bacteremia

Interventions

DIAGNOSTIC_TEST

Blood Culture

Blood Culture

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Josef Prazak, MD, PhD · Insel Gruppe AG, University Hospital Bern

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-03-01
Completion
2022-03-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05236283 on ClinicalTrials.gov